Escolar Documentos
Profissional Documentos
Cultura Documentos
INTRODUÇÃO À
DEPARTAMENTO DE EDUCAÇÃO INTEGRADA EM SAÚDE
BIOESTATÍSTICA: Capítulo
11
Hanna Tanure Werneck
Curso: Nutrição.
Orientador: Prof DSc. Dr. Luiz Carlos de Abreu
Vitória
2022
CAPÍTULO
11: Intervalo
de confiança
FORMAS DE EXPRESSAR RESULTADOS
2. Escolha o nível de confiança que você quer. Ache o valor de ex. subtraindo o nível de
confiança de 100%. Para 95% de confiança, calcule ex. = 100 - 95 = 5.
3. Procure, na Tabela de valores de t, o valor que fica no cruzamento da coluna "<α = 5%" é a
linha "graus de liberdade 14". Fonte: Sonia Vieira,2008
4. Você acha t = 2, 145.
• Então, o intervalo de 95% de confiança é:
• X+ 2,145 Sx
Number of women n = 1,495,499 n = 45,485 n = 141,622 n = 485,036 n = 395,331 n = 206,067 n = 102,942 n = 88,582 n = 29,630
% of total 100% 3.04% 9.47% 32.5% 26.4% 13.8% 6.88% 5.92% 1.98%
Age, years ± SD 28.3 ± 5.1 26.6 ± 5.0 27.5 ± 4.9 28.2 ± 4.9 28.5 ± 5.0 28.6 ± 5.2 28.6 ± 5.3 28.4 ± 5.3 28.6 ± 5.3
Height, mean ± SD 166 ± 6.3 166 ± 6.6 167 ± 6.2 167 ± 6.1 166 ± 6.3 166 ± 6.5 166 ± 6.5 166 ± 6.2 166 ± 6.5
Weight, mean ± SD 65.7 ± 12 48.7 ± 4.6 53.9 ± 4.2 59.2 ± 4.7 65.3 ± 5.3 72.0 ± 5.9 78.9 ± 6.5 87.9 ± 7.5 105.2 ± 12.4
BMI, mean ± SD 23.8 ± 4.0 17.6 ± 0.9 19.4 ± 0.4 21.3 ± 0.7 23.7 ± 0.7 26.1 ± 0.7 28.6 ± 0.7 32.0 ± 1.4 38.3 ± 3.3
First parity, n (%) 1,076,840 33,692 (74.0) 104,831 352,940 (72.6) 284,089 (71.9) 146,232 (70.1) 72,008 (70.0) 61,498 21,550 (72.7)
(72.0) (74.0) (69.4)
Smoking, n (%)* 226,261 (15.1) 8928 (19.7) 23,851 (16.9) 72,328 (14.9) 55,451 (14.0) 29,528 (14.4) 15,926 (15.5) 15,172 5077 (17.2)
(17.1)
Hypertension, n (%) 6694 (0.45) 110 (0.24) 338 (0.24) 1428 (0.29) 1532 (0.39) 1062 (0.52) 748 (0.73) 984 (1.11) 492 (1.66)
Diabetes, n (%) 9367 (0.63) 97 (0.21) 351 (0.25) 1941 (0.40) 2571 (0.65) 1742 (0.85) 1026 (1.00) 1099 (1.24) 540 (1.82)
Atrial fibrillation, n (%) 341 (0.02) 12 (0.02) 29 (0.02) 102 (0.02) 97 (0.03) 45 (0.02) 19 (0.02) 28 (0.03) 9 (0.03)
Heart failure n (%) 217 (0.01) 5 (0.01) 21 (0.02) 50 (0.01) 53 (0.01) 41 (0.02) 16 (0.02) 17 (0.02) 14 (0.05)
Cardiomyopathy, n (%) 142 (0.01) 5 (0.01) 8 (0.01) 45 (0.01) 33 (0.01) 21 (0.01) 9 (0.01) 14 (0.02) 7 (0.02)
Congenital heart disease, n (%) 3747 (0.3) 137 (0.3) 363 (0.3) 1070 (0.2) 968 (0.2) 550 (0.3) 273 (0.3) 272 (0.3) 114 (0.4)
Valvular disease, n (%) 730 (0.05) 25 (0.05) 79 (0.06) 223 (0.05) 184 (0.05) 89 (0.04) 54 (0.05) 56 (0.06) 20 (0.07)
Cancer, n (%) 5253 (0.35) 144 (0.32) 489 (0.35) 1587 (0.33) 1404 (0.36) 784 (0.38) 376 (0.37) 350 (0.40) 119 (0.40)
Education, n (%)†
≤9 years 214,635 (14.3) 9924 (21.9) 21,322 (15.1) 62,064 (13.0) 51,961 (13.1) 30,481 (14.8) 17,066 (16.6) 16,209 5608 (18.9)
(18.3)
10–12 years 701,805 (46.9) 20,831 (45.8) 63,571 (44.9) 218,586 (45.0) 183,435 (46.4) 100,040 (48.6) 51,903 (50.4) 46,948 16,491 (55.7)
(53.0)
>12 years 566,908 (37.9) 14,191 (31.2) 55,511 (39.2) 201,480 (41.5) 157,000 (39.7) 73,835 (35.8) 33,040 (32.1) 24,578 7273 (24.6)
(27.8)
Number of women n = 1,495,499 n = 45,485 n = 141,622 n = 485,840 n = 395,331 n = 206,067 n = 102,942 n = 88,582 n = 29,630
% of total 100% 3.04% 9.47% 32.5% 26.4% 13.8% 6.88% 5.92% 1.98%
AMI, n 3295 76 249 822 863 485 339 340 121
Age at AMI diagnosis, years ± SD 49.8 ± 7.8 48.6 ± 7.5 49.7 ± 7.9 50.3 ± 7.9 49.9 ± 7.8 49.8 ± 7.6 49.3 ± 8.0 49.8 ± 8.0 47.4 ± 6.9
Follow-up time, median (IQR) 16.3 (7.7–23.5) 17.5 (8.0– 18.1 (8.4– 18.4 (8.8– 16.4 (7.9– 14.4 (7.0– 13.5 (6.4– 12.8 (5.9– 10.1 (5.0–
23.5) 26.3) 27.0) 25.4) 22.2) 21.9) 21.5) 17.3)
Cases per 100,000 observation 13.4 (13.0– 9.9 (7.8– 10.2 (9.0– 9.6 (9.0– 13.2 (12.3– 15.4 (14.1– 22.4 (20.1– 27.0 (24.2– 34.7 (28.8–
years (95% CI) 13.9) 12.4) 11.5) 10.3) 14.1) 16.9) 24.9) 30.0) 41.4)
Ischemic stroke, n 4375 117 349 1311 1110 608 381 368 131
Age at ischemic stroke diagnosis, 47.3 ± 9.6 44.7 ± 9.6 46.2 ± 9.7 47.4 ± 9.6 47.2 ± 9.6 48.2 ± 9.5 47.9 ± 9.9 47.5 ± 9.2 46.6 ± 9.8
years ± SD
Follow-up time, median (IQR) 16.2 (7.7–23.5) 17.5 (7.9– 18.1 (8.3– 18.4 (8.7– 16.4 (7.9– 14.4 (7.0– 13.5 (6.4– 12.7 (5.9– 10.1 (5.0–
23.5) 26.3) 27.0) 25.4) 22.2) 21.9) 21.5) 17.3)
Cases per 100,000 observation 17.8 (17.3– 15.3 (12.7– 14.3 (12.8– 15.3 (14.5– 17.0 (16.0– 19.4 (17.9– 25.2 (22.7– 29.2 (26.3– 37.6 (31.4–
years (95% CI) 18.3) 18.3) 15.9) 16.2) 18.0) 21.0) 27.8) 32.3) 44.6)
Cardiovascular mortality, n 1429 39 122 397 331 205 127 152 56
Age at cardiovascular death, 50.4 (9.6) 47.9 (9.6) 50.2 (8.9) 49.7 (9.5) 50.5 (9.8) 50.9 (9.6) 51.3 (9.2) 51.2 (9.4) 50.9 (10.7)
years ± SD
Follow-up time, median (IQR) 16.3 (7.7–23.6) 17.5 (8.0– 18.1 (8.4– 18.4 (8.8– 16.4 (7.9– 14.4 (7.0– 13.5 (6.4– 12.8 (5.9– 10.2 (5.0–
23.5) 26.3) 27.0) 25.6) 22.3) 21.9) 21.5) 17.3)
Cases per 100,000 observation 5.8 (5.5–6.1) 5.1 (3.6–7.0) 5.0 (4.1–6.0) 4.6 (4.2–5.1) 5.1 (4.5–5.6) 6.5 (5.7–7.5) 8.4 (7.0– 12.0 (10.2– 16.0 (12.1–
years (95% CI) 10.0) 14.1) 20.8)
Mortality from any cause, n 16,596 555 1595 5431 4362 2118 1093 1127 315
Age at all-cause death, years ± SD 47.6 (9.8) 46.8 (9.8) 47.2 (9.9) 47.7 (9.8) 47.8 (9.9) 47.6 (9.9) 47.6 (9.6) 47.9 (9.8) 47.8 (10.3)
Follow-up time, median (IQR) 16.3 (7.7–23.6) 17.5 (8.0– 18.1 (8.4– 18.4 (8.8– 16.4 (7.9– 14.4 (7.0– 13.5 (6.4– 12.8 (5.9– 10.2 (5.0–
23.5) 26.3) 27.0) 25.6) 22.3) 21.9) 21.5) 17.3)
Cases per 100,000 observation 67.5 (66.4– 72.5 (66.6– 65.2 (62.0– 63.4 (61.7– 66.6 (64.6– 67.4 (64.5– 72.1 (67.9– 89.2 (84.0– 90.1 (80.4–
years (95% CI) 68.5) 78.8) 68.5) 65.1) 68.6) 70.3) 76.5) 94.5) 100.6)